Luye Pharma Group Intangible Assets

As of the most recent data (June 2026), LYPHF shows a intangible assets of $6.7B. That compares with $6.7B in the prior-year period — down 0.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LYPHF's intangible assets is now $6.7B (was $6.7B) — a 0.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Luye Pharma Group is outperforming or lagging.

Tracking LYPHF's intangible assets over time shows whether Luye Pharma Group is scaling, shrinking, or reshaping that part of the business. The current reading is $6.7B That compares with $6.7B in the prior-year period — down 0.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Luye Pharma Group's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $6.7B) with ownership activity and broader fundamentals.